Joanne L. Fothergill

Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.

Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa.

The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.

Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.

Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patient.

Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections.

Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections.

Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.

Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.

Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa.

Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis.

Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium.

Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients.

The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosa.

Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.

Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.

Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.

Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung Infections.

Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

The role of temperate bacteriophages in bacterial infection.

Temperate phages both mediate and drive adaptive evolution in pathogen biofilms.

High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections.

adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.

The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections.

The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.

Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.

Genomic characterisation of an international Pseudomonas aeruginosa reference panel indicates that the two major groups draw upon distinct mobile gene pools.

Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa.

Nitric Oxide Releasing Polymeric Coatings for the Prevention of Biofilm Formation.

Reservoirs of resistance: polymyxin resistance in veterinary-associated companion animal isolates of .

Effect of Polymer Demixed Nanotopographies on Bacterial Adhesion and Biofilm Formation.

A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas.

The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).

Transmission, adaptation and geographical spread of the Liverpool epidemic strain.

The Building Blocks of Antimicrobial Resistance in : Implications for Current Resistance-Breaking Therapies.

Bacterial keratitis: identifying the areas of clinical uncertainty.

Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance.

Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health.

Challenges and opportunities in the development of novel antimicrobial therapeutics for cystic fibrosis.

Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis.

Emerging strategies to target virulence in respiratory infections.

Multi-layered genome defences in bacteria.

Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.

Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.

Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance.

Optimization of a DNA extraction protocol for improving bacterial and fungal classification based on Nanopore sequencing.

Gelatin emulsion gels loaded with host defence peptides for the treatment of antibiotic-resistant infections.

Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review.